Abstract:<h3 class="Heading">Objectives</h3><p class="Para">To explore the utility of dynamic contrast-enhanced MRI (DCE-MRI) and readout-segmented diffusion-weighted imaging (RESOLVE-DWI) in the differentiation of nasopharyngeal carcinoma (NPC) and nasopharyngeal lymphoma (NPL).</p><h3 class="Heading">Methods</h3><p class="Para">Sixty-two patients with NPC and 39 patients with NPL who underwent DCE-MRI and RESOLVE-DWI examinations were evaluated. The time signal–intensity curve (TIC) types, time to peak (TTP), enhancement peak (EP), maximum contrast enhancement ratio (MCER), washout ratio (WR), apparent diffusion coefficient (ADC), and relative ADC (rADC) values were calculated. Statistical analysis between the two groups was performed to determine the statistical significance of each parameter. Receiver operating characteristic (ROC) curve analysis and binary logistic regression analysis were used to assess the diagnostic ability of single and combined metrics for distinguishing NPC from NPL.</p><h3 class="Heading">Results</h3><p class="Para">The most common TIC curve was type III in patients with NPC (<em class="EmphasisTypeItalic">n</em> = 26), while the majority of the curves were types I (<em class="EmphasisTypeItalic">n</em> = 14) and II (<em class="EmphasisTypeItalic">n</em> = 19) in patients with NPL. TTP, EP, MCER, ADC, and rADC were statistically significantly different between NPCs and NPLs (<em class="EmphasisTypeItalic">p</em> < 0.05). Among these factors, ADC revealed the most reliable diagnostic performance, followed by rADC, TTP, MCER, and EP. Moreover, the diagnostic efficiency of the combined DCE-MRI parameters was higher than that of TTP, MCER, and EP each alone. In addition, the combination of all DCE-MRI and DWI parameters together demonstrated the highest diagnostic efficiency (area under the curve = 0.961). However, none of the parameters was significantly different between keratinising NPC and non-keratinising NPC or between NK/T lymphoma and diffuse large B cell lymphoma (all <em class="EmphasisTypeItalic">p</em> > 0.05).</p><h3 class="Heading">Conclusion</h3><p class="Para">DCE-MRI and RESOLVE-DWI are effective in differentiating NPC from NPL.</p><h3 class="Heading">Key Points</h3><p class="Para"> <em class="EmphasisTypeItalic">• RESOLVE offers high image quality in the head and neck regions.</em> </p><p class="Para"> <em class="EmphasisTypeItalic">• Dynamic contrast-enhanced MRI and RESOLVE-DWI help clinicians to make the differential diagnosis between NPC and NPL.</em> </p><p class="Para"><em class="EmphasisTypeItalic">• The combination of all the DCE-MRI and DWI parameters together demonstrated the highest diagnostic efficiency compared with each parameter alone</em>.</p>

Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma

Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI

Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiating Glioblastoma, Primary Central Nervous System Lymphoma and Brain Metastatic Tumor.

Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient

Differentiation Of Primary Central Nervous System Lymphoma And High-Grade Glioma With Dynamic Susceptibility Contrast-Enhanced Perfusion Magnetic Resonance Imaging

Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients.

Multiparametric differentiation of intracranial central nervous system lymphoma and high-grade glioma using diffusion-, perfusion-, susceptibility-weighted magnetic resonance imaging, and spectroscopy

Differentiation of Primary Central Nervous System Lymphoma from High-Grade Glioma and Brain Metastasis Using Arterial Spin Labeling and Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Quantitative Evaluation of Ki-67 Labeling Index in Glioma with Transfer Constant Derived from Dynamic Contrast-Enhanced MRI

Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma

Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI

Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma

Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling

Differentiating Giant Cell Glioblastoma from Classic Glioblastoma With Diffusion-Weighted Imaging

[Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].

Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis

Quantitative Analysis of Permeability for Glioma Grading Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.

Differentiation between high-grade gliomas and solitary brain metastases based on multidiffusion MRI model quantitative analysis

Glioma Grading Capability: Comparisons among Parameters from Dynamic Contrast-Enhanced MRI and ADC Value on DWI

18F-FDG PET/CT in Immunocompetent Patients with Primary Central Nervous System Lymphoma: Differentiation from Glioblastoma and Correlation with DWI.